Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17725098 | 0.82 | CYP4F2 (0.47) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL9687573 | 0.79 | CYP4F2 (0.45) | CYP4F2CYP4A11NPSR1 | |
| SCHEMBL8393649 | 0.78 | CYP4F2 (0.50) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL2633876 | 0.77 | CYP4F2 (0.50) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL25188768 | 0.77 | CYP4F2 (0.50) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL9687113 | 0.77 | CYP4F2 (0.42) | CYP4F2CYP4A11NPSR1P2RX7 | |
| SCHEMBL9687116 | 0.77 | CYP4F2 (0.42) | CYP4F2CYP4A11NPSR1P2RX7 | |
| SCHEMBL2633828 | 0.76 | CYP4F2 (0.49) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL34476313 | 0.76 | CYP4F2 (0.49) | CYP4F2CYP4A11NPSR1P2RX7LMNA | |
| SCHEMBL3952155 | 0.75 | CYP4F2 (0.56) | CYP4F2CYP4A11NPSR1P2RX7LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023109540-A1 | HETEROCYCLIC COMPOUND WITH AKT KINASE INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 中国医药研究开发中心有限公司 | 2023-06-22 | — | — | WO | disclosed |